http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105764919-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2014-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_783bbd4e9f66778074a24ca15a2fe903
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b600b88d354d2831f9171a18d09638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9866c0765015a73d83df33488624993b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9f6637dbf57d2d7a793819fee1d67e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e0a6f8fa4bf5d8d28cbce74bab720f1
publicationDate 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105764919-A
titleOfInvention hPYY(1-36) with β-homoarginine substitution at position 35
abstract The present invention relates to PYY compounds and derivatives thereof in which the amino acid at the position corresponding to position 35 of hPYY(1-36) is replaced by β-homoarginine, which has a position linked to hPYY(1-36) The modifying group corresponding to the position of 7. The compounds of the present invention are selective Y2 receptor agonists. The present invention also relates to a pharmaceutical composition comprising such a PYY compound and a pharmaceutically acceptable auxiliary material, and the medical use of the PYY compound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114206375-A
priorityDate 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102573888-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102905722-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011058165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011033068-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102027007-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466904400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465118077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467196160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466469280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466291506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467792118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163534177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2879

Total number of triples: 41.